跳至主要内容
临床试验/NL-OMON31663
NL-OMON31663尚未招募3 期

Platelet Transfusion in Cerebral Haemorrhage - PATCH

Academisch Medisch Centrum0 个研究点目标入组 190 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
尚未招募
入组人数
190

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • - Age 18-75 years
  • - Patients with non-traumatic, supratentorial ICH confirmed by CT
  • - Haematoma volume < 150 cc
  • - Glagow Coma Scale score 8-15
  • - Platelet aggregation inhibitors used at least seven days preceding haemorrhage
  • - Treatment can be initiated within 6 hours after onset of first signs and within 1* hours of the CT scan
  • - Pre-stroke Rankin scale score 0 or 1 (No symptoms, No significant disability despite
  • symptoms; able to carry out all usual duties and activities)

排除标准

  • - Haematoma on CT compatible with epidural, subdural, aneurysmal or arterio-venous malformation (AVM) haematoma
  • - Planned surgical evacuation of haematoma within 24 hours after admission
  • - Presence of intraventricular blood if more than sedimentation in the posterior horns of the lateral ventricles
  • - Previous adverse reaction after platelet transfusion
  • - Previously legally incompetent adults
  • - Death appears imminent
  • - Known use of vitamin K antagonists (unless INR < 1.3)
  • - Known thrombocytopenia < 100 x 10E9/l
  • - History of coagulopathy

研究者

相似试验